Skip to content
Austin Top 50
Author:
PatentVest, Inc.
What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI’s Patent Portfolio
July 23, 2026
PatentVest Publishes New IP Legal Insights Article Examining Why Patent Prosecution Is Ready for AI
July 2, 2026
PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1
June 30, 2026
PatentVest to Present at Planet MicroCap Las Vegas on June 17
June 15, 2026
New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity
June 4, 2026
PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana
May 19, 2026
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market
May 8, 2026
Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
April 29, 2026
Duchesnay launches a contraceptive vaginal system that can be used for up to a full year
April 7, 2026
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
March 31, 2026
1
2
Next Page
→